A global virtual event dedicated to the latest cardio-renal-metabolic disease treatment strategies to support better patient outcomes

Overview

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) to be held 4–5 April 2025.

Cardiovascular-kidney-metabolic (CKM) health reflects the complex interplay among metabolic risk factors, diabetes, chronic kidney disease and the cardiovascular system, significantly impacting global morbidity and mortality. To address these challenges, TMA and KDIGO have launched the e-SPACE CRM programme, empowering clinicians worldwide to enhance patient outcomes.

The 2025 e-SPACE CRM conference will deliver free, cutting-edge virtual education, uniting global thought leaders in cardiology, nephrology and diabetology. Its multidisciplinary approach ensures a balance of global and regional insights while maximising geographical reach.

The programme features concise expert presentations, live panel discussions and interactive "meet the expert" sessions, offering participants the chance to engage directly with world-class faculty.

Building on the success of e-SPACE CRM 2024, which gathered 60 experts and over 2,000 healthcare professionals, the 2025 event aims to elevate professional development while advancing KDIGO’s mission to improve care for patients with kidney disease globally.

Guided by an esteemed international faculty and supported by TMA’s expertise in education delivery, e-SPACE CRM 2025 is set to be a leading online conference. The event will also be submitted for EBAC® accreditation.

Watch e-SPACE CRM 2024 on-demand here.

Programme

(Please note this programme is subject to change)

Day 1

8:10 AM - 8:50 AM (BST)
Keynote Session
Cardiorenal Metabolic: CRM the Future

Enrique Caballero and Stefan Anker



9:10 AM - 9:50 AM (BST)
Meet the Experts
Advancing Patient Care in Heart, Kidney and Metabolic Diseases: Practical Insights From the DCRM 2.0 Practice Recommendations

Shelley Zieroth, Yehuda Handelsman and Stefan Anker



Supported by an unrestricted educational grant from Boehringer Ingelheim


10:00 AM - 11:00 AM (BST)
Plenary Session
Session 1 - Foundational Therapies in CRM

Chairs – Stephan von Haehling and Manisha Sahay

  • SGLT2 Inhibitors – Francesco Cosentino

  • MRAs – Joao Ferreira

  • GLP-1 RAs – Tina Vilsbøll

  • Panel Discussion



11:10 AM - 11:50 AM (BST)
Meet the Experts
Improving Identification, Evaluation and Treatment of HF: Learning of REVOLUTION HF

Lisa Anderson and Antoni Bayés-Genís



Supported by unrestricted educational grant funding from AstraZeneca


12:00 PM - 1:00 PM (BST)
Plenary Session
Session 2 - Overcoming Treatment Inertia in CRM Disease

Chair – Stefano del Prato and Yuhui Zhang

  • The Cardiologist Perspective – Gianluigi Savarese

  • The Nephrologist Perspective – Matthew Weir

  • The Diabetologist Perspective – Julia Mader

  • The Primary Care Physician Perspective – Jean Philippe Minart

  • Panel Discussion

 



1:10 PM - 1:50 PM (BST)
Keynote Session
KDIGO Guideline Updates 2025: Anaemia in CKD

David Wheeler and Stefan Anker



2:10 PM - 2:50 PM (BST)
Meet the Experts
Iron Deficiency in Cardiorenal Disease: Interdisciplinary Crosstalk

Beatriz Fernandez-Fernandez, Stefan Anker and Iain Macdougall



Supported by an unrestricted educational grant from CSL Vifor


3:00 PM - 4:00 PM (BST)
Plenary Session
Session 3 - Managing Key Parameters in CRM

Chairs – Jozine ter Maaten and Mitja Lainscak

  • Potassium Levels – Patrick Rossignol

  • Albuminaria – Shahzeb Khan

  • NT ProBNPs – Antoni Bayés-Genís

  • Low eGFR – Finnian McCausland

  • Panel Discussion

 



4:10 PM - 4:50 PM (BST)
Meet the Experts
Hyperkalaemia Management: Learning From REALIZE-K

James Burton and Gianluigi Savarese



Supported by unrestricted educational grant funding from AstraZeneca


5:00 PM - 6:00 PM (BST)
Plenary Session
Session 4 - AOMs Clinical Experience

Chairs – Marc-Andre Cornier and Wei Ling Lau

  • The Nephrologist View – Peter Rossing

  • The Diabetologist View – Scott Isaac

  • The Cardiologist View – Javed Butler

  • Muscle-Wasting Associated With AOMs – Stefan Anker

  • Panel Discussion

 



7:00 PM - 8:00 PM (BST)
Meet the Experts
Cardiac Resynchronisation Therapy: A Cornerstone of Heart Failure Care

Chairs – Andrea Russo and Christophe Leclercq

  • CRT: Still a Cornerstone of Heart Failure Care? – William Abraham

  • Optimising CRT in Practice: Patient Selection, Timing and Post-implant Care – Wilfried Mullens

  • CRT in HF: The Patient’s Perspective – Marc Bains, Cecilia Linde and Steven Macari

  • Panel Discussion – All faculty (joined by Javed Butler)

 



Supported by Medtronic


8:00 PM - 9:00 PM (BST)
Plenary Session
Session 5 - Managing HFpEF in 2025

Chairs – Alice Cheng and Nisha Bansal

  • Diagnosis Best Practices – Ambarish Pandey

  • Current Therapies in HFpEF – Jennifer Green

  • Management of Patients With HFpEF and CKD – Nisha Bansal

  • Future Therapies in HFpEF Perspective – Mark Petrie

  • Panel Discussion

 



9:10 PM - 9:50 PM (BST)
Meet the Experts
REPLAY: Advancing Patient Care in Heart, Kidney and Metabolic Diseases: Practical Insights From the DCRM 2.0 Practice Recommendations

Shelley Zieroth, Yehuda Handelsman and Stefan Anker



Supported by an unrestricted educational grant from Boehringer Ingelheim


10:00 PM - 11:00 PM (BST)
Plenary Session
Session 6 - Inclusivity and Adherence in CRM Disease

Chairs – Dinushika Mohottige and Antonio Ceriello

  • The Cardiologist Perspective – Anu Lala-Trindade

  • The Nephrologist Perspective – David Mariuma

  • The Diabetologist Perspective – Kamlesh Khunti

  • Panel Discussion – Faculty will be joined by Ankeet Bhatt

 




Day 2

9:10 AM - 9:50 AM (BST)
Meet the Experts
REPLAY: Improving Identification, Evaluation and Treatment of HF: Learning of REVOLUTION HF

Lisa Anderson and Antoni Bayés-Genís



Supported by unrestricted educational grant funding from AstraZeneca


10:00 AM - 11:00 AM (BST)
Plenary Session
Session 7 - Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease

Chairs – Debbie Shawcross and Michael Böhm

  • MASLD and CVD – Faiez Zannad

  • Screening and Diagnosis – Nicholas Chew

  • Management – Cyrielle Caussy

  • Panel Discussion – Faculty will be joined by Andrew Coats

 



11:10 AM - 11:50 AM (BST)
Special Session
PROVIDE Project

12:00 PM - 1:00 PM (BST)
Plenary Session
Session 8 - Managing Heart and Kidney in Patients With T2D

Chair – Ahmed Bennis and Gloria Ashuntantang

  • The Cardiologist Perspective – Cristina Gavina

  • The Nephrologist Perspective – David Wheeler

  • The Diabetologist Perspective – Antonio Ceriello

  • Panel Discussion

 



1:00 PM - 2:00 PM (BST)
Meet the Experts
REPLAY: Cardiac Resynchronisation Therapy: A Cornerstone of Heart Failure Care

Chairs – Andrea Russo and Christophe Leclercq

  • CRT: Still a Cornerstone of Heart Failure Care? – William Abraham

  • Optimising CRT in Practice: Patient Selection, Timing and Post-implant Care – Wilfried Mullens

  • CRT in HF: The Patient’s Perspective – Marc Bains, Cecilia Linde and Steven Macari

  • Panel Discussion – All faculty (joined by Javed Butler)

 



Supported by Medtronic


2:10 PM - 2:50 PM (BST)
Meet the Experts
Practical Implementation of Non-steroidal Mineralocorticoid Receptor Antagonist to Reduce Cardiorenal Risk

Shelley Zieroth, Peter Rossing and Muthiah Vaduganathan



Supported by an unrestricted educational grant from Bayer


3:00 PM - 4:00 PM (BST)
Plenary Session
Session 9 - The Role of Non-Steroidal MRAs in CRM

Chair – John McMurray and Susanne Nicholas

  • Difference Between NS and Standard MRAs – Gerasimos Filippatos

  • Non-Steroidal MRAs: The Evidence in 2025 – Muthiah Vaduganathan

  • Initiating Treatment in Patients With Poor Kidney Function – Hiddo Heerspink

  • Finerenone in Patients With Mildly Reduced or Preserved Ejection Fraction – Kieran Docherty

  • Panel Discussion

 



4:10 PM - 4:50 PM (BST)
Meet the Experts
Effective Patient Communication in Obesity and Cardiovascular

  • Welcome and Introduction – Laurence Sherman

  • The What, Why and How of Patient Communication – All faculty: Robert Kushner, Vicki Mooney and Laurence Sherman

 



5:00 PM - 6:00 PM (BST)
Plenary Session
Session 10 - Anaemia and Iron Deficiency

Chairs – Ewa Jankowska and Wolfgang Winkelmayer

  • Management of CRM Disease – Wolfgang Winkelmayer

  • FAIR-HF 2 Results – Stefan Anker

  • IV Iron Meta Analysis – Robert Mentz

  • Future Perspectives – John Cleland

  • Panel Discussion

 



6:00 PM - 7:00 PM (BST)
Meet the Experts
REPLAY: Iron Deficiency in Cardiorenal Disease: Interdisciplinary Crosstalk

Beatriz Fernandez-Fernandez, Stefan Anker and Iain Macdougall



Supported by an unrestricted educational grant from CSL Vifor



Course Leadership

Nisha Bansal

Nisha Bansal

University of Washington, Seattle, US

Antonio Ceriello

Antonio Ceriello

IRCCS MultiMedica, Milan, IT

David Wheeler

David Wheeler

University College London, London, UK

Shelley Zieroth

Shelley Zieroth

University of Manitoba, Winnipeg, CA

Faculty

William Abraham
William Abraham

The Ohio State University, Columbus, US

Lisa Anderson
Lisa Anderson

St George’s Hospital, London, UK

Stefan Anker
Stefan Anker

Charité Campus Virchow-Klinikum, Berlin, DE

Gloria Ashuntantang
Gloria Ashuntantang

Yaoundé General Hospital, Yaoundé, CM

Marc Bains
Marc Bains

HeartLife Foundation

Antoni Bayés-Genís
Antoni Bayés-Genís

Hospital Germans Trias i Pujol, Barcelona, ES

Ahmed Bennis
Ahmed Bennis

Ibn Rochd University Hospital, Casablanca, MA

Ankeet Bhatt
Ankeet Bhatt

Kaiser Permanente San Francisco Medical Center, San Francisco, US

Michael Böhm
Michael Böhm

Saarland University Hospital, Homburg, DE

James Burton
James Burton

University of Leicester, Leicester, UK

Javed Butler
Javed Butler

University of Mississippi Medical Center, Jackson, US

Enrique Caballero
Enrique Caballero

Harvard Medical School, Boston, US

Cyrielle Caussy
Cyrielle Caussy

Hôpital Lyon Sud, Lyon, FR

Alice Cheng
Alice Cheng

University of Toronto, Toronto, CA

Nicholas Chew
Nicholas Chew

National University Health System, Kent Ridge, SG

John Cleland
John Cleland

University of Glasgow, Glasgow, UK

Andrew Coats
Andrew Coats

Monash University, Melbourne, AU

Marc-Andre Cornier
Marc-Andre Cornier

Medical University of South Carolina, Charleston, US

Francesco Cosentino
Francesco Cosentino

Karolinska Institute, Stockholm, SE

Stefano del Prato
Stefano del Prato

University of Pisa, Pisa, IT

Kieran Docherty
Kieran Docherty

University of Glasgow, Glasgow, UK

Beatriz Fernandez-Fernandez
Beatriz Fernandez-Fernandez

Jiménez Díaz Foundation University Hospital, Madrid, ES

Joao Ferreira
Joao Ferreira

University of Porto, Porto, PT

Gerasimos Filippatos
Gerasimos Filippatos

National and Kapodistrian University of Athens, Athens, GR

Cristina Gavina
Cristina Gavina

University of Porto, Porto, PT

Jennifer Green
Jennifer Green

Duke Clinical Research Institute, Durham, US

Yehuda Handelsman
Yehuda Handelsman

The Metabolic Institute of America, Los Angeles, US

Hiddo Heerspink
Hiddo Heerspink

University Medical Center Groningen, Groningen, NL

Scott Isaac
Scott Isaac

Atlanta Endocrine Associates, Cumming, US

Ewa Jankowska
Ewa Jankowska

Wrocław Medical University, Wrocław, PL

Shahzeb Khan
Shahzeb Khan

Baylor Scott & White Health, Dallas, US

Kamlesh Khunti
Kamlesh Khunti

University of Leicester, Leicester, UK

Robert Kushner
Robert Kushner

Northwestern University Feinberg School of Medicine, Chicago, US

Mitja Lainscak
Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota, SI

Anu Lala-Trindade
Anu Lala-Trindade

The Mount Sinai Hospital, New York, US

Wei Ling Lau
Wei Ling Lau

University of California, Irvine, US

Christophe Leclercq
Christophe Leclercq

Hospital Pontchaillou of Rennes, Rennes, FR

Cecilia Linde
Cecilia Linde

Karolinska Institute, Stockholm, SE

Ian Macdougall
Ian Macdougall

King’s College Hospital, London, UK

Julia Mader
Julia Mader

Medical University of Graz, Graz, AT

David Mariuma
David Mariuma

University of Washington, Seattle, US

Finnian McCausland
Finnian McCausland

Brigham and Women's Hospital, Boston, US

John McMurray
John McMurray

University of Glasgow, Glasgow, UK

Robert Mentz
Robert Mentz

Duke University, Durham, US

Jean-Philippe Minart
Jean-Philippe Minart

Jawa Production/Riviera CheckUp, Cannes, FR

Dinushika Mohottige
Dinushika Mohottige

Icahn School of Medicine at Mount Sinai, New York, US

Vicki Mooney
Vicki Mooney

European Coalition for People Living with Obesity

Wilfried Mullens
Wilfried Mullens

Hospital Oost-Limburg, Genk, BE

Susanne Nicholas
Susanne Nicholas

David Geffen School of Medicine at UCLA, Los Angeles, US

Ambarish Pandey
Ambarish Pandey

University of Texas Southwestern Medical Center, Dallas, US

Mark Petrie
Mark Petrie

University of Glasgow, Glasgow, UK

Giuseppe Rosano
Giuseppe Rosano

St Georges Medical School, London, UK

Patrick Rossignol
Patrick Rossignol

CHRU de Nancy, Nancy, FR

Peter Rossing
Peter Rossing

Steno Diabetes Center Copenhagen, Herlev, DK

Andrea Russo
Andrea Russo

Cooper Medical School of Rowan University, Camden, US

Manisha Sahay
Manisha Sahay

Osmania General Hospital, Hyderabad, IN

Gianluigi Savarese
Gianluigi Savarese

Karolinska Institute, Stockholm, SE

Debbie Shawcross
Debbie Shawcross

King's College London, London, UK

Lawrence Sherman
Lawrence Sherman

Meducate Global

Jozine ter Maaten
Jozine ter Maaten

University Medical Center Groningen, Groningen, NL

Muthiah Vaduganathan
Muthiah Vaduganathan

Brigham and Women's Hospital, Massachusetts, US

Tina Vilsbøll
Tina Vilsbøll

Steno Diabetes Center Copenhagen, Herlev, DK

Stephan von Haehling
Stephan von Haehling

University Medical Centre of Gottingen, Goettingen, DE

Matthew Weir
Matthew Weir

University of Maryland, College Park, US

Wolfgang Winkelmayer
Wolfgang Winkelmayer

Baylor College of Medicine, Houston, US

Faiez Zannad
Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy, FR

Yuhui Zhang
Yuhui Zhang

Fuwai Hospital, Beijing, CN

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world

  • Describe the complexity and interlink between the three conditions

  • Discuss existing guidelines and best approaches for screening patients

  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies

  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists

  • Nephrologists

  • Diabetologists

  • General Practitioners (GPs)

  • HF Specialists

  • Nurses, Pharmacists and other Allied Healthcare Professionals

Sponsors

If you’re interested in becoming an educational partner or sponsor at this event, please contact [email protected]

About KDIGO

KDIGO is a global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.

KDIGO’s mission is to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines.

For more information on KDIGO, please visit https://kdigo.org.

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science

  • We work hands-on with our community

  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.

Please contact [email protected] should you have any queries.